首页> 外国专利> PHARMACEUTICAL FORMULATION CONTAINING BUSPIRONE HYDROCHLORIDE FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE RATE OF ANTIDEPRESSANT

PHARMACEUTICAL FORMULATION CONTAINING BUSPIRONE HYDROCHLORIDE FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE RATE OF ANTIDEPRESSANT

机译:含盐酸丁苯哌啶的医药配方,可控制抗抑郁药的释放速度,用于口服

摘要

PURPOSE: A pharmaceutical formulation for oral administration of antidepressant with controlled release property is provided to enhance drug efficiency with reduced side effects.;CONSTITUTION: A pharmaceutical composition for oral administration of antidepressant with controlled release property contains buspirone hydrochloride as a pharmacologically active ingredient; glyceryl behenate or hydrogenated cotton seed as a lipophilic polymer; and hydroxypropylmethylcellulose, hydroxypropropylcellulose, or carboxymethylcellulose sodium as a hydrophilic polymer.;COPYRIGHT KIPO 2010
机译:用途:提供口服给药的具有控释性质的抗抑郁药的药物制剂,以提高药物效率并减少副作用。山hen酸甘油酯或氢化棉籽,为亲脂性聚合物;以及作为亲水性聚合物的羟丙基甲基纤维素,羟丙基丙基纤维素或羧甲基纤维素钠。; COPYRIGHT KIPO 2010

著录项

  • 公开/公告号KR20100077959A

    专利类型

  • 公开/公告日2010-07-08

    原文格式PDF

  • 申请/专利权人 YOON KOOG RYUL;

    申请/专利号KR20080136054

  • 发明设计人 YOON KOOG RYUL;

    申请日2008-12-29

  • 分类号A61K31/505;A61K47/48;A61P25/18;

  • 国家 KR

  • 入库时间 2022-08-21 18:32:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号